Opioids and cognition by patients with chronic pain: A systematic review;Opióides e a cognição de doentes com dor crônica: Revisão sistemática

Revista da Associacao Medica Brasileira

Volumn 54, Issue 6, 2008, Pages 529-536

  Kurita, Geana Paula ^a   De Pimenta, Cibele Andrucioli Mattos ^a,b   Nobre, Moacyr Roberto Cuce ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Depto ENC   (Brazil)

Author keywords

Cancer; Cognition; Opioids; Pain; Systematic review

Indexed keywords

NARCOTIC ANALGESIC AGENT;

CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DRUG EFFECT; HUMAN; METHODOLOGY; PAIN; REVIEW; STANDARD; TREATMENT OUTCOME;

ANALGESICS, OPIOID; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; COGNITION; COGNITION DISORDERS; HUMANS; PAIN; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 60149095708     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302008000600018     Document Type: Review

References (30)

1. a ed. Rio de Janeiro: McGraw-Hill; 2003. p.427-64.
2. Lawlor PG. The panorama of opiod-related cognitive dysfunction in patients with cancer. Cancer. 2002;94:1836-53.
3. Daeninck PJ, Bruera E. Opiod use in cancer pain: is a more liberal approach enhancing toxicity? Acta Anaesthesiol Scand. 1999;43:924-38.
4. Bruera E, Pereira J. Recent developments in palliative cancer care. Acta Oncol. 1998;37:749-57.
5. Zacny JP. A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol. 1995;3:432-66.
6. Clausen TG. International opioid consumption. Acta Anaesthesiol Scand. 1997;41:162-5.
7. Phillips B, Ball C, Sackett DL, Badenoch D, Straus S, Haynes B, Dawes M. Oxford Centre for Evidence-based Medicine Levels of Evidence, 2001. [cited 2008 feb 10]. Available from: http://www.cebm.net/ index.aspx?o=1025.
8. Raja SN, Haythornthwaite JA, Pappagallo M, Clark M, Travison G, Sabeens S. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;59:1015-21.
9. Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet. 1996;347:143-7.
10. Haythorthwaite JA, Menefee LA, Quatrano-Piacentini AL. Outcome of chronic opiod therapy for non-cancer pain. J Pain Symptom Manage. 1998;15:185-94.
11. Hendler N, Cimini C, MA T, Long D. A comparison of cognitive impairment due to benzodiazepines and to narcotics. Am J Psychiatry. 1980;137:828-30.
12. Tassain V, Attal N, Fletcher D, Brasseur L, Dégueux P, Chauvin M, et al. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain. 2003;104:389-400.
13. Menefee LA, Frank ED, Crerand C, Jalali S, Park J, Sanschagrin K, et al. The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Med. 2004;5:42-9.
14. Jamison RN, Schein JR, Vallow S, Ascher S, Vorsonger GJ, Katz NP. Neuropsychological effects of long-term opiod use in chronic pain patients. J Pain Symptom Manage. 2003;26:913-21.
15. Lorenz J, Beck H, Bromm B. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain. 1997;73:369-75.
16. Galski T, Williams B, Ehle HT. Effects of opioids on driving ability. J Pain Symptom Manage. 2000;19:200-8.
17. Sabatowski R, Schwalen S, Rettig K, Herberg KW, Kasper SM, Radbruch L. Driving ability under long-term treatment with transdermal fentanyl. J Pain Symptom Manage. 2003;25:38-47.
18. Sjøgren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. J Pain Symptom Manage. 2000;19:100-8.
19. Sjøgren P, Olsen AK, Thomsen AB, Dalberg J. Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status. Pain. 2000;86:237-45.
20. Clemons M, Regnard C, Appleton T. Alertness, cognition and morphine in patients with advanced cancer. Cancer Treat Rev. 1996;22:451-68.
21. Pita G. Disturbances in recent memory and behavioural changes caused by the treatment with intraventricular morphine administration (IVM) in severe cancer pain. Hum Psychopharmacol Clin Exp. 1998;13:315-23.
22. Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet. 1995;346:667-70.
23. Sjøgren P, Banning A. Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids. Pain. 1989;39:5-11.
24. Hart RP, Wade JB, Martelli MF. Cognitive impairment in patients with chronic pain: the significance of stress. Curr Pain Headache Rep. 2003;7:116-26.
25. Chapman SL, Byas-Smith MG, Reed BA. Effects of intermediate and longterm use of opioids on cognition in patients with chronic pain. Clin J Pain. 2002;18:S83-S90.
26. Kurita GP. Alteração cognitiva e o tratamento da dor oncológica. [tese] São Paulo: Escola de Enfermagem. Universidade de São Paulo; 2006.
27. Kurita GP, Pimenta CAM. Cognitive impairment in cancer pain patients receiving opioids: a pilot study. Cancer Nurs. 2008;30:49-57 .
28. Kress HG, Kraft B. Opioid medication and driving ability. Eur J Pain. 2005;9:141-4.
29. O'Neill WM. The cognitive and psychomotor effects of opioid drugs in cancer pain management. Cancer Surv. 1994;21:67-84.
30. Ersek M, Cherrier MM, Overman SS, Irving GA. The cognitive effects of opioids. Pain Manage Nurs. 2004;5:75-93.